Dodd laboratory: Metabolic Neuroscience
Dr Garron Dodd
+61 3 9035 3918
View Dr Dodd's latest PubMed publications listing here
Metabolic diseases, such as obesity and type-2 diabetes, are amongst the world's biggest and fasting growing health concerns. Currently, metabolic disease costs more than $2 trillion of global health expenditure and causes 6.5 million deaths globally each year. With the ever-increasing metabolic disease epidemic and the insurmountable costs of treating co-morbidities (cancer, cardiovascular disease and stroke), there has never been a more desperate need to discover novel pharmacological treatments.
The brain plays a critical role in coordinating metabolism; from controlling how much fat we store to how much food we eat. Although the neuronal circuitry underlying metabolic disease is incredibly complex, recent advances in the transgenic tools by which we can manipulate the brain may now make this possible. Using cutting-edge technologies and innovative in vivo models it is our research mission to uncover the brain mechanisms underlying obesity and type 2 diabetes to define novel treatments for metabolic disease.
Garron Dodd, Head of Laboratory
Professor Tony Tiganis, Head of Metabolism, Diabetes and Obesity Program, Monash Biomedicine Discovery Institute
Professor Jen Bruning, Director, Max Planck Institute for Metabolism Research
Professor Tamas Horvath, Professor of Comparative Medicine and Director of the Neurobiology of Metabolism Program, Yale University
A/Professor Zane Andrews, Deputy Head of Metabolism, Diabetes and Obesity Program, Monash Biomedicine Discovery Institute
Professor Michael Cowley, Head of the Department of Physiology, Monash University
Professor David Spanswick, Monash Biomedicine Discovery Institute
View Dr Dodd's Research Grants listing here
This research project is available to PhD, Masters by Research, Honours, Master of Biomedical Science to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.
Dodd GT, Tiganis T. 2017. AUSTRALIA Patent: 2017902239. Methods and compositions for treatment of obesity.
This patent describes several novels pharmacological approaches to specifically target hypothalamic neurons to promote thermogenesis to treat metabolic disease
School Research Themes
For further information about this research, please contact Head of Laboratory Dr Garron Dodd
Department / Centre
Unit / Centre
MDHS Research library
Explore by researcher, school, project or topic.